KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Assets Average (2019 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Assets Average for 7 consecutive years, with $501.7 million as the latest value for Q4 2025.

  • Quarterly Assets Average fell 8.61% to $501.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $501.7 million through Dec 2025, down 8.61% year-over-year, with the annual reading at $526.1 million for FY2025, 12.36% down from the prior year.
  • Assets Average hit $501.7 million in Q4 2025 for Adaptive Biotechnologies, up from $493.6 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $1.1 billion in Q1 2021 to a low of $493.6 million in Q3 2025.
  • Historically, Assets Average has averaged $748.9 million across 5 years, with a median of $759.6 million in 2023.
  • Biggest five-year swings in Assets Average: grew 22.46% in 2021 and later dropped 22.86% in 2024.
  • Year by year, Assets Average stood at $958.0 million in 2021, then fell by 9.14% to $870.4 million in 2022, then decreased by 20.8% to $689.4 million in 2023, then dropped by 20.38% to $548.9 million in 2024, then dropped by 8.61% to $501.7 million in 2025.
  • Business Quant data shows Assets Average for ADPT at $501.7 million in Q4 2025, $493.6 million in Q3 2025, and $503.7 million in Q2 2025.